The effects of peritumoral therapeutic vaccination with IL-2-secreting cells on growth of MC38 colon tumours in mice, local NO production and sentinel lymph node cells activation

Advances in Experimental Medicine and Biology

Volumn 495, Issue , 2001, Pages 385-388

  Pajtasz Piasecka, Elzbieta ^a   Kuśnierczyk, Halina ^a   Krawczyk, Krzysztof P ^b   Piasecki, Egbert ^a   Elas, Martyna ^b   Radzikowski, Czeslaw ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL ACTIVATION; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR GROWTH; TUMOR REGRESSION; TUMOR REJECTION; VACCINATION;

ANIMALS; CANCER VACCINES; COLONIC NEOPLASMS; INTERFERONS; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; NITRIC OXIDE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0035699827     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-0685-0_56     Document Type: Article

References (3)

1. Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma
2. Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent
3. Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and interleukin-2-secreting cells in a mouse colon cancer model